SG10201704303VA - Mixture for the inhibition of melanin biosynthesis - Google Patents

Mixture for the inhibition of melanin biosynthesis

Info

Publication number
SG10201704303VA
SG10201704303VA SG10201704303VA SG10201704303VA SG10201704303VA SG 10201704303V A SG10201704303V A SG 10201704303VA SG 10201704303V A SG10201704303V A SG 10201704303VA SG 10201704303V A SG10201704303V A SG 10201704303VA SG 10201704303V A SG10201704303V A SG 10201704303VA
Authority
SG
Singapore
Prior art keywords
inhibition
mixture
melanin biosynthesis
melanin
biosynthesis
Prior art date
Application number
SG10201704303VA
Inventor
Paoli Ambrosi Gianfranco De
Original Assignee
General Topics S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Topics S R L filed Critical General Topics S R L
Publication of SG10201704303VA publication Critical patent/SG10201704303VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG10201704303VA 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis SG10201704303VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000092A ITBS20120092A1 (en) 2012-06-04 2012-06-04 MIXTURE FOR THE INHIBITION OF MELANIN BIOSYNTHESIS

Publications (1)

Publication Number Publication Date
SG10201704303VA true SG10201704303VA (en) 2017-07-28

Family

ID=46758827

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201408053TA SG11201408053TA (en) 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis
SG10201704303VA SG10201704303VA (en) 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201408053TA SG11201408053TA (en) 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis

Country Status (14)

Country Link
US (1) US20150110725A1 (en)
EP (1) EP2854783B1 (en)
JP (1) JP2015518877A (en)
KR (1) KR20150023544A (en)
CN (1) CN104507462A (en)
EA (1) EA030102B1 (en)
ES (1) ES2668848T3 (en)
IN (1) IN2014MN02468A (en)
IT (1) ITBS20120092A1 (en)
MY (1) MY169101A (en)
PL (1) PL2854783T3 (en)
SG (2) SG11201408053TA (en)
TR (1) TR201806726T4 (en)
WO (1) WO2013182996A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071701B2 (en) 2016-06-30 2021-07-27 Symrise Ag Medicament and cosmetic composition comprising resorcinol derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002053448A (en) * 2000-07-28 2002-02-19 Pentapharm Ltd Outdoor cosmetic
DE10324566A1 (en) * 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Use of diphenylmethane derivatives as tyrosinase inhibitors
US20090162305A1 (en) 2006-01-05 2009-06-25 Symrise Gmbh & Co. Kg Formulations of low oil content comprising diphenylmethane derivatives
CN101139288B (en) * 2006-09-07 2011-06-15 黑龙江大学 Method for preparating ethyl linoleate by catalysis of composite solid ultra-strong acid
KR101362619B1 (en) * 2008-02-20 2014-02-13 이엘씨 매니지먼트 엘엘씨 Topical compositions and methods for whitening skin
FR2939669B1 (en) * 2008-12-17 2011-03-25 Oreal COSMETIC METHOD FOR CONTROLLING SKIN BLIND INDUCED BY UV RADIATION; Compositions.
SG10202009963PA (en) * 2011-01-07 2020-11-27 Allergan Inc Melanin modification compositions and methods of use

Also Published As

Publication number Publication date
IN2014MN02468A (en) 2015-07-10
ITBS20120092A1 (en) 2013-12-05
EA201492153A1 (en) 2015-05-29
WO2013182996A1 (en) 2013-12-12
ES2668848T3 (en) 2018-05-22
TR201806726T4 (en) 2018-06-21
JP2015518877A (en) 2015-07-06
US20150110725A1 (en) 2015-04-23
PL2854783T3 (en) 2018-08-31
EA030102B1 (en) 2018-06-29
MY169101A (en) 2019-02-18
SG11201408053TA (en) 2015-01-29
EP2854783B1 (en) 2018-02-14
EP2854783A1 (en) 2015-04-08
KR20150023544A (en) 2015-03-05
CN104507462A (en) 2015-04-08

Similar Documents

Publication Publication Date Title
HK1212701A1 (en) Formulations of enzalutamide
HK1207861A1 (en) Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1
EP3715345B8 (en) Preparation of lfa-1 inhibitor
HK1207078A1 (en) Inhibition of enzymes
EP2852403A4 (en) Methods for modification of tissues
EP2861225A4 (en) Saturated acyl guanid1ne for inhibition of f1f0-atpase
HK1211024A1 (en) Inhibitors of syk syk
IL236312A0 (en) Preparation of 18f-fluciclovine
HK1201066A1 (en) Pyranopyridone inhibitors of tankyrase
IL250684A0 (en) Improved processes for the preparation of 1-aryl-5-alkyl pyrazole compounds
PL2888228T3 (en) Inhibitors of cd40-traf6 interaction
HK1210225A1 (en) Procedure for the production of tiacumicin
EP2680843A4 (en) Derivatives of pyrazole-substituted amino-heteroaryl compounds
ZA201502350B (en) Solid form of hihydro-pyrido-oxazine derivative
EP2857379A4 (en) Method for the synthesis of curcumin
ZA201303874B (en) Processes for the preparation of enamines
ZA201303870B (en) Processes for the preparation of enamines
SG10201704303VA (en) Mixture for the inhibition of melanin biosynthesis
AP2014007760A0 (en) Stabilized pharmaceutical formulations of a potentHCV inhibitor
ZA201303871B (en) Processes for the preparation of enamines
GB201007519D0 (en) Means for inhibiting the expression of rragb
SI2928896T1 (en) Solid form of dihydro-pyrido-oxazine derivative
AU2012905067A0 (en) IMPROVED INHIBITORS OF Grb7
GB201204590D0 (en) Prodrugs of thiazolamine compounds